Related Experiment Videos
Purinergic signaling in microglia in the pathogenesis of neuropathic pain
1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University.
Abstract:
Nerve injury often causes debilitating chronic pain, referred to as neuropathic pain, which is refractory to currently available analgesics including morphine. Many reports indicate that activated spinal microglia evoke neuropathic pain. The P2X4 receptor (P2X4R), a subtype of ionotropic ATP receptors, is upregulated in spinal microglia after nerve injury by several factors, including CC chemokine receptor CCR2, the extracellular matrix protein fibronectin in the spinal cord, interferon regulatory factor 8 (IRF8) and IRF5. Inhibition of P2X4R function suppresses neuropathic pain, indicating that microglial P2X4R play a key role in evoking neuropathic pain.
Insights
Activated spinal microglia contribute to neuropathic pain following nerve injury. Targeting the P2X4 receptor (P2X4R) on these cells offers a potential strategy for managing chronic pain resistant to conventional treatments.
Area of Science:
- Neuroscience
- Pain Research
- Immunology
Background:
- Nerve injury frequently results in chronic neuropathic pain, a condition poorly managed by existing analgesics.
- Activated spinal microglia are implicated in the development and maintenance of neuropathic pain.
- The P2X4 receptor (P2X4R) is a key mediator in microglial activation and subsequent pain signaling.
Purpose of the Study:
- To investigate the role of P2X4R in spinal microglia in the context of nerve injury-induced neuropathic pain.
- To identify factors that upregulate P2X4R expression in spinal microglia post-nerve injury.
- To evaluate the therapeutic potential of inhibiting P2X4R function for neuropathic pain.
Main Methods:
- Utilized animal models of nerve injury to induce neuropathic pain.
- Examined the expression and localization of P2X4R in spinal cord microglia.
- Investigated the influence of factors like CCR2, fibronectin, IRF8, and IRF5 on P2X4R upregulation.
- Assessed the effects of P2X4R inhibition on pain behaviors.
Main Results:
- P2X4R expression is significantly upregulated in spinal microglia following nerve injury.
- Factors including CCR2, fibronectin, IRF8, and IRF5 contribute to this P2X4R upregulation.
- Pharmacological inhibition of P2X4R function effectively suppressed established neuropathic pain.
- Microglial P2X4R activation is a critical component in the pathogenesis of neuropathic pain.
Conclusions:
- Microglial P2X4R is a crucial mediator in the development of neuropathic pain.
- Targeting microglial P2X4R represents a promising therapeutic avenue for chronic pain conditions.
- Understanding the regulatory mechanisms of P2X4R offers insights into novel pain management strategies.